Cargando…

NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology

HIV-1 proviral single-genome sequencing by limiting-dilution polymerase chain reaction (PCR) amplification is important for differentiating the sequence-intact from defective proviruses that persist during antiretroviral therapy (ART). Intact proviruses may rebound if ART is interrupted and are the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wright, Imogen A., Delaney, Kayla E., Katusiime, Mary Grace K., Botha, Johannes C., Engelbrecht, Susan, Kearney, Mary F., van Zyl, Gert U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534097/
https://www.ncbi.nlm.nih.gov/pubmed/34685559
http://dx.doi.org/10.3390/cells10102577
_version_ 1784587473022615552
author Wright, Imogen A.
Delaney, Kayla E.
Katusiime, Mary Grace K.
Botha, Johannes C.
Engelbrecht, Susan
Kearney, Mary F.
van Zyl, Gert U.
author_facet Wright, Imogen A.
Delaney, Kayla E.
Katusiime, Mary Grace K.
Botha, Johannes C.
Engelbrecht, Susan
Kearney, Mary F.
van Zyl, Gert U.
author_sort Wright, Imogen A.
collection PubMed
description HIV-1 proviral single-genome sequencing by limiting-dilution polymerase chain reaction (PCR) amplification is important for differentiating the sequence-intact from defective proviruses that persist during antiretroviral therapy (ART). Intact proviruses may rebound if ART is interrupted and are the barrier to an HIV cure. Oxford Nanopore Technologies (ONT) sequencing offers a promising, cost-effective approach to the sequencing of long amplicons such as near full-length HIV-1 proviruses, but the high diversity of HIV-1 and the ONT sequencing error render analysis of the generated data difficult. NanoHIV is a new tool that uses an iterative consensus generation approach to construct accurate, near full-length HIV-1 proviral single-genome sequences from ONT data. To validate the approach, single-genome sequences generated using NanoHIV consensus building were compared to Illumina(®) consensus building of the same nine single-genome near full-length amplicons and an average agreement of 99.4% was found between the two sequencing approaches.
format Online
Article
Text
id pubmed-8534097
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85340972021-10-23 NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology Wright, Imogen A. Delaney, Kayla E. Katusiime, Mary Grace K. Botha, Johannes C. Engelbrecht, Susan Kearney, Mary F. van Zyl, Gert U. Cells Article HIV-1 proviral single-genome sequencing by limiting-dilution polymerase chain reaction (PCR) amplification is important for differentiating the sequence-intact from defective proviruses that persist during antiretroviral therapy (ART). Intact proviruses may rebound if ART is interrupted and are the barrier to an HIV cure. Oxford Nanopore Technologies (ONT) sequencing offers a promising, cost-effective approach to the sequencing of long amplicons such as near full-length HIV-1 proviruses, but the high diversity of HIV-1 and the ONT sequencing error render analysis of the generated data difficult. NanoHIV is a new tool that uses an iterative consensus generation approach to construct accurate, near full-length HIV-1 proviral single-genome sequences from ONT data. To validate the approach, single-genome sequences generated using NanoHIV consensus building were compared to Illumina(®) consensus building of the same nine single-genome near full-length amplicons and an average agreement of 99.4% was found between the two sequencing approaches. MDPI 2021-09-28 /pmc/articles/PMC8534097/ /pubmed/34685559 http://dx.doi.org/10.3390/cells10102577 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wright, Imogen A.
Delaney, Kayla E.
Katusiime, Mary Grace K.
Botha, Johannes C.
Engelbrecht, Susan
Kearney, Mary F.
van Zyl, Gert U.
NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
title NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
title_full NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
title_fullStr NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
title_full_unstemmed NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
title_short NanoHIV: A Bioinformatics Pipeline for Producing Accurate, Near Full-Length HIV Proviral Genomes Sequenced Using the Oxford Nanopore Technology
title_sort nanohiv: a bioinformatics pipeline for producing accurate, near full-length hiv proviral genomes sequenced using the oxford nanopore technology
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534097/
https://www.ncbi.nlm.nih.gov/pubmed/34685559
http://dx.doi.org/10.3390/cells10102577
work_keys_str_mv AT wrightimogena nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology
AT delaneykaylae nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology
AT katusiimemarygracek nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology
AT bothajohannesc nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology
AT engelbrechtsusan nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology
AT kearneymaryf nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology
AT vanzylgertu nanohivabioinformaticspipelineforproducingaccuratenearfulllengthhivproviralgenomessequencedusingtheoxfordnanoporetechnology